Interestingly, emerging evidence indicated an opposite regulatory role of METTL3 and METTL14 in several cancers, such as glioblastoma [20, 21], HCC [19, 22], and colorectal cancer (CRC) [23, 24]. This evidence concerns the gene METTL14 and hepatocellular carcinoma.